Retatrutide
Triple Agonist Peptide
A GIP/GLP-1/glucagon triple receptor agonist under active investigation for metabolic research applications.
Select fill weight
Purity
99.2%
Batch
KL-2600
Storage
-20°C
Retatrutide is a synthetic triple-receptor agonist engineered to act on GIP, GLP-1, and glucagon receptors simultaneously, making it one of the most closely studied compounds in metabolic peptide research.
Klinity Labs sources and verifies every batch through independent third-party laboratories before release, with full chromatography and mass spectrometry data published as a Certificate of Analysis.
For in-vitro laboratory research use only by qualified professionals. Not for human or veterinary use, consumption, or therapeutic application. Not intended to diagnose, treat, cure, or prevent any disease.